Affected Systems |
|
|
|
endocrine/exocrine glands
|
√
|
|
abnormal mammary gland development
|
√
|
|
impaired mammary gland growth during pregnancy
|
√
|
|
abnormal mammary gland epithelium morphology
|
√
|
|
abnormal mammary gland duct morphology
|
√
|
|
abnormal branching of the mammary ductal tree
|
√
|
|
abnormal mammary duct terminal end bud morphology
|
√
|
|
abnormal lactation
|
√
|
|
hematopoietic system
|
|
√
|
decreased T cell number
|
|
√
|
decreased alpha-beta T cell number
|
|
√
|
decreased CD4-positive, alpha-beta T cell number
|
|
√
|
abnormal CD8-positive, alpha-beta cytotoxic T cell morphology
|
|
√
|
immune system
|
|
√
|
decreased T cell number
|
|
√
|
decreased alpha-beta T cell number
|
|
√
|
decreased CD4-positive, alpha-beta T cell number
|
|
√
|
abnormal CD8-positive, alpha-beta cytotoxic T cell morphology
|
|
√
|
integument
|
√
|
|
abnormal mammary gland development
|
√
|
|
impaired mammary gland growth during pregnancy
|
√
|
|
abnormal mammary gland epithelium morphology
|
√
|
|
abnormal mammary gland duct morphology
|
√
|
|
abnormal branching of the mammary ductal tree
|
√
|
|
abnormal mammary duct terminal end bud morphology
|
√
|
|
abnormal lactation
|
√
|
|
neoplasm
|
|
√
|
increased metastatic potential
|
|
√
|
increased incidence of induced tumors
|
|
√
|
decreased tumor latency
|
|
√
|
reproductive system
|
√
|
|
impaired mammary gland growth during pregnancy
|
√
|
|